STML News
Archived Headlines
- Stemline Therapeutics slashes deal size in half 10/22/12
- Stemline Therapeutics postpones IPO 08/07/12
- 6 US IPOs planned for the week of Aug 6 08/06/12
- 4 US IPOs planned for the week of Jul 30 07/30/12
- Stemline Therapeutics set terms for $42 million US IPO 07/20/12
See more
Weekly Recap: Most January pricings since 2006, Zoetis surges in debut
After last week's five deals, January finished the month with 12 pricings, making it the second most active January in the past decade, trailing only the 15 pricings in January 2006. Though pricings to start the year could signal healthy deal flow in...read more
Biotech Stemline Therapeutics prices upsized IPO at $10, the low end of the range
Stemline Therapeutics, a biotech developing treatments that target cancer stem cells and tumor bulk, raised $33 million by offering 3.3 million shares (1.0 million more than expected) at $10, the low end of the range of $10 to $12. Stemline Therapeutics plans to...read more
5 US IPOs planned for the week of Jan 28
The following IPOs are expected to price this week: Gladstone Land (LAND), an externally managed REIT planning to acquire agricultural real estate, plans to raise $50...read more
Stemline Therapeutics increases proposed IPO deal size
Stemline Therapeutics, a biotech developing treatments that target cancer stem cells and tumor bulk, raised the proposed deal size for its upcoming IPO on Wednesday. The New York, NY-based company now plans to raise $25 million by offering 2.3 million shares at...read more